Table: RaQualia Pharma - 6-MTH group results

RaQualia Pharma

14/08/2026 07:33

    Aug 14 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to  
                Jun 30, 2026        Jun 30, 2025      Dec 31, 2026 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales             1.46                1.54              3.98     
                 (-5.2 pct)          (+8.9 pct)                    
  Operating     loss 338 mln        loss 190 mln        165 mln    
                                                      (-65.9 pct)  
  Recurring     loss 326 mln        loss 291 mln         86 mln    
                                                      (-80.4 pct)  
  Net           loss 466 mln        loss 354 mln      loss 63 mln  
  EPS          loss 18.10 yen      loss 15.49 yen    loss 2.58 yen 
  Ann Div                                NIL              NIL      
  -Q2 div            NIL                 NIL                       
  -Q4 div                                NIL              NIL      
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T